Bronchoalveolar Lavage Fluid-Isolated Biomarkers for the Diagnostic and Prognostic Assessment of Lung Cancer.
biomarkers
bronchoalveolar lavage fluid
lung neoplasm
tumor microenvironment
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
25 Nov 2022
25 Nov 2022
Historique:
received:
31
10
2022
revised:
18
11
2022
accepted:
22
11
2022
entrez:
23
12
2022
pubmed:
24
12
2022
medline:
24
12
2022
Statut:
epublish
Résumé
Lung cancer is considered one of the most fatal malignant neoplasms because of its late detection. Detecting molecular markers in samples from routine bronchoscopy, including many liquid-based cytology procedures, such as bronchoalveolar lavage fluid (BALF), could serve as a favorable technique to enhance the efficiency of a lung cancer diagnosis. BALF analysis is a promising approach to evaluating the tumor progression microenvironment. BALF's cellular and non-cellular components dictate the inflammatory response in a cancer-proliferating microenvironment. Furthermore, it is an essential material for detecting clinically significant predictive and prognostic biomarkers that may aid in guiding treatment choices and evaluating therapy-induced toxicities in lung cancer. In the present article, we have reviewed recent literature about the utility of BALF analysis for detecting markers in different stages of tumor cell metabolism, employing either specific biomarker assays or broader omics approaches.
Identifiants
pubmed: 36552956
pii: diagnostics12122949
doi: 10.3390/diagnostics12122949
pmc: PMC9776496
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Clin Cancer Res. 1999 Mar;5(3):617-20
pubmed: 10100714
Cancer Epidemiol Biomarkers Prev. 2010 Oct;19(10):2665-72
pubmed: 20802023
N Engl J Med. 2015 May 21;372(21):2018-28
pubmed: 25891174
Adv Exp Med Biol. 2016;952:41-49
pubmed: 27573644
J Natl Cancer Inst. 1999 Feb 17;91(4):332-9
pubmed: 10050866
Chest. 2004 Feb;125(2):712-22
pubmed: 14769756
Cancer Immunol Immunother. 2017 Feb;66(2):161-170
pubmed: 27866241
J Thorac Oncol. 2016 Dec;11(12):2238-2240
pubmed: 27423391
Chest. 2018 Sep;154(3):664-677
pubmed: 29698718
J Clin Oncol. 2004 Jun 15;22(12):2363-70
pubmed: 15197197
J Immunother Cancer. 2014 Jun 18;2:19
pubmed: 24991413
Oncotarget. 2015 Aug 7;6(22):18748-79
pubmed: 26125440
J Thorac Oncol. 2014 Oct;9(10):1504-12
pubmed: 25105437
Lancet Oncol. 2017 Jan;18(1):31-41
pubmed: 27932067
Chest. 2018 Dec;154(6):1416-1423
pubmed: 30189190
Int J Oncol. 2012 Mar;40(3):825-32
pubmed: 22108652
Asian Pac J Cancer Prev. 2015;16(1):201-4
pubmed: 25640352
Asian Pac J Cancer Prev. 2013;14(4):2443-6
pubmed: 23725155
Radiat Oncol. 2020 Oct 27;15(1):246
pubmed: 33109238
J Cancer. 2020 Feb 3;11(8):2113-2122
pubmed: 32127938
J Cancer. 2017 Sep 30;8(17):3585-3591
pubmed: 29151944
Sci Rep. 2017 Feb 07;7:42190
pubmed: 28169345
Front Immunol. 2018 Feb 12;9:232
pubmed: 29483918
Cancer Lett. 2011 May 28;304(2):144-53
pubmed: 21396771
J Proteome Res. 2013 Aug 2;12(8):3689-96
pubmed: 23802180
J Proteomics. 2016 Apr 14;138:106-14
pubmed: 26917472
Lung Cancer. 2015 Dec;90(3):516-21
pubmed: 26505137
Cancer Res. 2012 Nov 15;72(22):5692-701
pubmed: 22962272
Transl Lung Cancer Res. 2020 Jun;9(3):693-704
pubmed: 32676331
Anticancer Res. 2015 Apr;35(4):1873-80
pubmed: 25862841
Respir Res. 2017 Feb 1;18(1):29
pubmed: 28143484
Eur Respir J. 2017 Aug 10;50(2):
pubmed: 28798088
J Natl Cancer Inst. 2013 Sep 18;105(18):1385-93
pubmed: 23940286
Adv Exp Med Biol. 2015;852:49-58
pubmed: 25753556
Mol Cancer. 2018 Jan 27;17(1):15
pubmed: 29374476
Front Oncol. 2021 Jan 14;10:568433
pubmed: 33520694
J Proteomics. 2016 Aug 11;145:197-206
pubmed: 27255828
Thorac Cancer. 2018 Aug;9(8):911-915
pubmed: 29806739
Clinics (Sao Paulo). 2011;66(11):1879-86
pubmed: 22086517
Med Sci Monit. 2019 Apr 17;25:2819-2834
pubmed: 30994108
Oncotarget. 2017 Apr 11;8(31):50704-50714
pubmed: 28881596
J Clin Oncol. 2015 Jun 20;33(18):2004-12
pubmed: 25897158
Cancer Sci. 2018 Apr;109(4):1177-1184
pubmed: 29363250
Eur Respir J. 2014 Jun;43(6):1740-9
pubmed: 24743967
Lung Cancer. 2004 Apr;44(1):23-32
pubmed: 15013580
Lung Cancer. 2016 Dec;102:89-95
pubmed: 27987594
Respirology. 1998 Jun;3(2):131-7
pubmed: 9692523
Cancer Res. 2022 Aug 16;82(16):2838-2847
pubmed: 35748739
Anticancer Res. 2017 Jun;37(6):3295-3299
pubmed: 28551680
Clin Respir J. 2020 Sep;14(9):829-838
pubmed: 32502326
BBA Clin. 2017 Mar 06;7:97-104
pubmed: 28331811
Metallomics. 2018 Oct 17;10(10):1444-1451
pubmed: 30168824
J Radiat Res. 2009 May;50(3):177-82
pubmed: 19377267
Mol Oncol. 2012 Apr;6(2):140-6
pubmed: 22356776
J Thorac Oncol. 2018 Aug;13(8):1076-1082
pubmed: 29763666
Respir Res. 2020 Jun 9;21(1):142
pubmed: 32517757
Int J Radiat Biol. 2003 Mar;79(3):159-67
pubmed: 12745880
JCI Insight. 2022 May 9;7(9):
pubmed: 35389889
Sci Rep. 2014 Jul 07;4:5595
pubmed: 24999009
Cancer Sci. 2016 Jul;107(7):1001-5
pubmed: 27145431
Clin Epigenetics. 2021 Oct 7;13(1):185
pubmed: 34620221
Int J Cancer. 2013 Mar 1;132(5):1098-104
pubmed: 22930255
Mol Oncol. 2020 Sep;14(9):2163-2175
pubmed: 32441866
Cytokine. 2010 Apr;50(1):30-6
pubmed: 20044268
Sci Rep. 2021 Jun 3;11(1):11736
pubmed: 34083661
Expert Rev Respir Med. 2020 Mar;14(3):329-337
pubmed: 31865801
Int J Biol Markers. 1987 Sep-Dec;2(3):151-6
pubmed: 2836526
J Thorac Cardiovasc Surg. 2021 Feb;161(2):419-429.e16
pubmed: 32340803
Clin Exp Pharmacol Physiol. 2019 Dec;46(12):1074-1083
pubmed: 31381177
Genes Chromosomes Cancer. 2014 Sep;53(9):713-24
pubmed: 24764226
Clin Epigenetics. 2018 May 18;10:65
pubmed: 29796116
Thorac Cancer. 2018 Aug;9(8):1032-1040
pubmed: 29927090
Dis Markers. 2012;32(5):329-35
pubmed: 22674413
Int J Radiat Oncol Biol Phys. 2001 Mar 1;49(3):641-8
pubmed: 11172944
Cancer Immunol Immunother. 2020 Dec;69(12):2547-2560
pubmed: 32583155
J Thorac Oncol. 2011 Sep;6(9):1615-6
pubmed: 21849859
Respir Res. 2021 Dec 28;22(1):322
pubmed: 34963470
Transl Lung Cancer Res. 2014 Feb;3(1):15-22
pubmed: 25806277
J Clin Invest. 2019 Jul 16;129(10):4305-4315
pubmed: 31310589
Ann Thorac Med. 2017 Oct-Dec;12(4):252-258
pubmed: 29118857
Maedica (Bucur). 2010 Dec;5(4):250-7
pubmed: 21977166
Ther Adv Med Oncol. 2010 Nov;2(6):351-65
pubmed: 21789147
Oncol Lett. 2017 Aug;14(2):1568-1580
pubmed: 28789381
Clin Chim Acta. 2015 Oct 23;450:78-82
pubmed: 26232753
Cancer. 2004 Dec 25;102(6):348-54
pubmed: 15481085
Clin Chem Lab Med. 2017 Aug 28;55(10):1489-1495
pubmed: 28195541
J Clin Oncol. 2012 Jul 20;30(21):2691-7
pubmed: 22614989
Int J Biol Markers. 2014 Dec 09;29(4):e328-36
pubmed: 24519547
Eur J Intern Med. 2011 Oct;22(5):522-6
pubmed: 21925065
Respir Med Case Rep. 2017 May 30;21:171-175
pubmed: 28616379
Cancer Genomics Proteomics. 2015 Jan-Feb;12(1):39-48
pubmed: 25560643
Oncotarget. 2017 Dec 26;9(5):6346-6355
pubmed: 29464077
Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1385-90
pubmed: 19231104
Technol Cancer Res Treat. 2021 Jan-Dec;20:15330338211041465
pubmed: 34519585
Cancer Cytopathol. 2016 Sep;124(9):621-9
pubmed: 27153322
PeerJ. 2021 May 14;9:e11448
pubmed: 34040898
Exp Oncol. 2012 Dec;34(4):348-53
pubmed: 23302994
Eur Respir J. 1999 Oct;14(4):735-7
pubmed: 10573213
Clin Chim Acta. 2013 Apr 18;419:57-61
pubmed: 23415723
Hum Immunol. 2016 Oct;77(10):912-915
pubmed: 27474372
Int Immunopharmacol. 2014 May;20(1):74-80
pubmed: 24598169
J Natl Cancer Inst. 1999 Feb 17;91(4):299-301
pubmed: 10050857
Cancer Cytopathol. 2015 Oct;123(10):620-8
pubmed: 26235264
Br J Dermatol. 2017 Apr;176(4):1060-1063
pubmed: 27291635
J Transl Med. 2020 Jun 17;18(1):243
pubmed: 32552826
Pediatr Pulmonol. 2019 Dec;54(12):1948-1956
pubmed: 31496123